UMIN ID: UMIN000005111
Registered date:21/02/2011
Chemotherapy for recurrent malignant glioma with combined usage of temozolomide and GSK3beta-inhibiting drugs
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Recurrent glioblastoma |
| Date of first enrollment | 2011/02/01 |
| Target sample size | 6 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | GSK cocktail is daily administered from the detection of recurrence until unavailable state. |
Outcome(s)
| Primary Outcome | Safety |
|---|---|
| Secondary Outcome | Efficacy: response on MRI and progression-free survival |
Key inclusion & exclusion criteria
| Age minimum | 15years-old |
|---|---|
| Age maximum | 90years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1) Allergy to the drugs administered. 2) Patients who are pregnant and/or breast feeding. 3) Any patients disqualified by a study physician because of medical, psychological, or any other factors. |
Related Information
| Primary Sponsor | Department of Neurosurgery Kanazawa University |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Department of Neurosurgery Kanazawa University |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Mitsutoshi Nakada |
| Address | 13-1 Takaramachi, Kanazawa Japan |
| Telephone | 076-265-2384 |
| Affiliation | Kanazawa University Department of Neurosurgery |
| scientific contact | |
| Name | Jun-ichiro Hamada |
| Address | 13-1 Takaramachi, Kanazawa Japan |
| Telephone | 076-265-2384 |
| Affiliation | Kanazawa University Department of Neurosurgery |